200 related articles for article (PubMed ID: 23550958)
1. Whole genome sequencing identifies SCN2A mutation in monozygotic twins with Ohtahara syndrome and unique neuropathologic findings.
Touma M; Joshi M; Connolly MC; Grant PE; Hansen AR; Khwaja O; Berry GT; Kinney HC; Poduri A; Agrawal PB
Epilepsia; 2013 May; 54(5):e81-5. PubMed ID: 23550958
[TBL] [Abstract][Full Text] [Related]
2. Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence.
Melikishvili G; Dulac O; Gataullina S
Epilepsy Behav; 2020 Oct; 111():107187. PubMed ID: 32603808
[TBL] [Abstract][Full Text] [Related]
3. The finding of a new heterozygous mutation site of the SCN2A gene in a monozygotic twin family carrying and exhibiting genetic epilepsy with febrile seizures plus (GEFS+) using targeted next-generation sequencing.
Liu XW; Li W; Han T; Wei K; Qiao S; Su L; Chi Z
Clin Neurol Neurosurg; 2018 Jun; 169():86-91. PubMed ID: 29635106
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome.
Nakamura K; Kato M; Osaka H; Yamashita S; Nakagawa E; Haginoya K; Tohyama J; Okuda M; Wada T; Shimakawa S; Imai K; Takeshita S; Ishiwata H; Lev D; Lerman-Sagie T; Cervantes-Barragán DE; Villarroel CE; Ohfu M; Writzl K; Gnidovec Strazisar B; Hirabayashi S; Chitayat D; Myles Reid D; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Hayasaka K; Matsumoto N; Saitsu H
Neurology; 2013 Sep; 81(11):992-8. PubMed ID: 23935176
[TBL] [Abstract][Full Text] [Related]
5. [Phenotype study of SCN2A gene related epilepsy].
Zeng Q; Zhang YH; Yang XL; Zhang J; Liu AJ; Liu XY; Jiang YW; Wu XR
Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):518-523. PubMed ID: 29996185
[No Abstract] [Full Text] [Related]
6. Association between SCN1A and SCN2A mutations and clinical/EEG features in Chinese patients from epilepsy or severe seizures.
Kong Y; Yan K; Hu L; Wang M; Dong X; Lu Y; Wu B; Wang H; Yang L; Zhou W
Clin Chim Acta; 2018 Aug; 483():14-19. PubMed ID: 29649454
[TBL] [Abstract][Full Text] [Related]
7. Paternal germline mosaicism of a SCN2A mutation results in Ohtahara syndrome in half siblings.
Zerem A; Lev D; Blumkin L; Goldberg-Stern H; Michaeli-Yossef Y; Halevy A; Kivity S; Nakamura K; Matsumoto N; Leshinsky-Silver E; Saitsu H; Lerman-Sagie T
Eur J Paediatr Neurol; 2014 Sep; 18(5):567-71. PubMed ID: 24814476
[TBL] [Abstract][Full Text] [Related]
8. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
[TBL] [Abstract][Full Text] [Related]
9. Ketogenic diet as a successful early treatment modality for SCN2A mutation.
Turkdogan D; Thomas G; Demirel B
Brain Dev; 2019 Apr; 41(4):389-391. PubMed ID: 30415926
[TBL] [Abstract][Full Text] [Related]
10. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
11. SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures.
Howell KB; McMahon JM; Carvill GL; Tambunan D; Mackay MT; Rodriguez-Casero V; Webster R; Clark D; Freeman JL; Calvert S; Olson HE; Mandelstam S; Poduri A; Mefford HC; Harvey AS; Scheffer IE
Neurology; 2015 Sep; 85(11):958-66. PubMed ID: 26291284
[TBL] [Abstract][Full Text] [Related]
12. Neonatal Onset of Epilepsy of Infancy with Migrating Focal Seizures Associated with a Novel GABRB3 Variant in Monozygotic Twins.
Štěrbová K; Vlčková M; Klement P; Neupauerová J; Staněk D; Zůnová H; Seeman P; Laššuthová P
Neuropediatrics; 2018 Jun; 49(3):204-208. PubMed ID: 29444535
[TBL] [Abstract][Full Text] [Related]
13. Novel SCN2A mutation in a family associated with juvenile-onset myoclonus: Case report.
Huang Q; Yu L; Ma M; Qi H; Wu Y
Medicine (Baltimore); 2019 Feb; 98(8):e14698. PubMed ID: 30813219
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.
Schwarz N; Hahn A; Bast T; Müller S; Löffler H; Maljevic S; Gaily E; Prehl I; Biskup S; Joensuu T; Lehesjoki AE; Neubauer BA; Lerche H; Hedrich UBS
J Neurol; 2016 Feb; 263(2):334-343. PubMed ID: 26645390
[TBL] [Abstract][Full Text] [Related]
15. Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a.
Calhoun JD; Hawkins NA; Zachwieja NJ; Kearney JA
Epilepsia; 2016 Jun; 57(6):e103-7. PubMed ID: 27112236
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features.
Liang JS; Lin LJ; Yang MT; Wang JS; Lu JF
Brain Dev; 2017 Nov; 39(10):877-881. PubMed ID: 28709814
[TBL] [Abstract][Full Text] [Related]
17.
Vlachou V; Larsen L; Pavlidou E; Ismayilova N; Mazarakis ND; Scala M; Pantazi M; Mankad K; Kinali M
J Genet; 2019 Jun; 98(2):. PubMed ID: 31204721
[TBL] [Abstract][Full Text] [Related]
18. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain.
Liao Y; Anttonen AK; Liukkonen E; Gaily E; Maljevic S; Schubert S; Bellan-Koch A; Petrou S; Ahonen VE; Lerche H; Lehesjoki AE
Neurology; 2010 Oct; 75(16):1454-8. PubMed ID: 20956790
[TBL] [Abstract][Full Text] [Related]
19. Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis.
Martin HC; Kim GE; Pagnamenta AT; Murakami Y; Carvill GL; Meyer E; Copley RR; Rimmer A; Barcia G; Fleming MR; Kronengold J; Brown MR; Hudspith KA; Broxholme J; Kanapin A; Cazier JB; Kinoshita T; Nabbout R; ; Bentley D; McVean G; Heavin S; Zaiwalla Z; McShane T; Mefford HC; Shears D; Stewart H; Kurian MA; Scheffer IE; Blair E; Donnelly P; Kaczmarek LK; Taylor JC
Hum Mol Genet; 2014 Jun; 23(12):3200-11. PubMed ID: 24463883
[TBL] [Abstract][Full Text] [Related]
20. SCN2A mutation in an infant presenting with migrating focal seizures and infantile spasm responsive to a ketogenic diet.
Su DJ; Lu JF; Lin LJ; Liang JS; Hung KL
Brain Dev; 2018 Sep; 40(8):724-727. PubMed ID: 29625812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
